ArticleCancer medicine2022

Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.

Zhiyuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.